A.SuzukiA.et al
These check-ins allow your provider to monitor your progress, assess tolerability, and adjust dosing when medically appropriate
Research May 20, 2026 GLP-1 and Restaurants: Shifting Habits, Not Shrinking Demand Restaurants remain deeply embedded in the lifestyles of GLP-1 users According to a recent consumer survey conducted by the National Restaurant Association, roughly one in eight adults are currently taking some form of GLP-1 medication, and that is expected to rise significantly in the months and years ahead
GSTT ( n = 16) tended to perform 3.0 (0.53.5) adjustments per participant, whilst North Bristol ( n = 7) performed more adjustments, 4.0 (3.06.0)
We've spent the last 50 years supporting patients with the tools, education and encouragement they need to achieve truly sustainable results.
GLP-1 Agonists and Pancreatitis Risk: Reassessing an Old Concern with New Evidence A Renewed Look at an Old Controversy Ever since GLP-1 receptor agonists (GLP-1 RAs) entered clinical practice for diabetes and obesity, their metabolic benefits have been undeniable